ABSTRACT
Introduction
Laryngeal mask airways (LMA) are widely used in anaesthesia and resuscitation. (1, 2) They are easy to use and require minimal training, which makes them an excellent alternative airway device for personnel who are not familiar with airway management. (3) (4) (5) Health care workers have been giving drugs through airway devices for decades. (6) Among these devices, the tracheal tube (TT) is most commonly used. However, considerable training is required to acquire and maintain the skill of tracheal intubation. (7) Our previous studies revealed that using a catheter inserted through an LMA into the trachea to deliver drugs is as effective as using the TT route. (8, 9) However, the ease of passing a catheter and documenting its correct position are still under investigation. (10, 11) Trevisanuto et al. and Spain et al. reported that delivering surfactant and bronchodilator via an LMA is effective in treating neonatal respiratory distress syndrome and bronchospasm, respectively. (12, 13) Our previous studies showed that LMA-administered epinephrine was well absorbed through the mucosa of the airway but that, compared with the TT route, the same dose produced a lower plasma level. (8, 9) The optimal LMA-administered dose of epinephrine is unknown. We therefore gave increasing doses of LMAadministered epinephrine to identify a dose equipotent to a standard TT dose and to clarify the characteristics of drug absorption via this route.
Materials and Methods
The Animal Care and Users Committee of the Chi-Mei Medical Center approved the study and the animals were cared for in accordance with national and institutional guidelines. Thirty domestic Yorkshire pigs, nine males and 23 females, weighing 16.5-27 kg were anesthetized with intravenous pentothal 30 mg/kg and randomly assigned to one of five groups: Control Group: 10 mL of distilled water via the TT. TT Group: epinephrine 50 g/kg via the TT. LMA-2 Group: epinephrine 100 g/kg via the LMA (twice the TT group dose). LMA-4 Group: epinephrine 200 g/kg via the LMA (four times the TT group dose). LMA-6 Group: epinephrine 300 g/kg via the LMA (six times the TT group dose). All doses of epinephrine were diluted to a total volume of 10 mL with distilled water. The animals were intubated with a cuffed TT (internal diameter 5 mm) and size 3 LMA (LMA-Class TM , Laryngeal Mask Company, Henley on Thames, UK) (figure 1). We used a fibre-optic bronchoscope to confirm the position of the TT and to ensure that the opening of the larynx faced directly towards the lower aperture of the LMA. The animals were ventilated via the TT with a respiratory rate of 15 breath/min, tidal volume 20 mL/kg and FiO 2 1.0. All animals were attached to a three-lead ECG monitor and given an infusion of 0.9% normal saline solution at 20 mL/h throughout the experiment. A carotid or femoral catheter was inserted for continuous heart rate (HR) and arterial blood pressure (BP) monitoring. An intravenous flush of heparin 3000 IU was given to avoid intra-catheter clot formation. To achieve steady state conditions, a 20-min stabilization period followed the completion of the above procedures. We recorded baseline HR and BP. Subsequently, we deflated the cuff of the TT in the LMA-2, LMA-4 and LMA-6 groups to facilitate spraying epinephrine into the trachea through the LMA. In the control and TT groups, epinephrine and distilled water were delivered via the TT and in the other groups via the LMA. Drug administration was followed by five forceful artificial respirations using an Ambu Bag. The cuff of the TT was re-inflated after epinephrine administration in the LMA groups. HR and BP were recorded continuously for 15 min following medication delivery. At the end of the experiment, the animals were killed by injection of potassium chloride solution 10 mEq. The methods of medication administration are presented in figure 1 ; all other procedures are illustrated in figure 2. All experimental results are presented as medians unless otherwise noted (table 1). The differences in HR and BP between the five groups were compared using the Kruskal-Wallis followed by MannWhitney U tests. The intra-animal changes in hemodynamic variables were investigated using the Wilcoxon signed rank test. All statistical tests were performed at a two-tailed significance level of 0.05. LMA, laryngeal mask airway; TT, tracheal tube.
AP, arterial pressure; HR, heart rate; LMA, laryngeal mask airway; TT, tracheal tube. 
Results
There were no significant differences in biometric data between the five groups (table 1). The hemodynamic changes following epinephrine administration via the TT or LMA are illustrated in figures 3-6. The LMA-6 and TT groups had an increase in systolic arterial pressure (SAP) at 1 min post-injection (p=0.028, both groups). The response lasted for 11 min and 8 min, respectively. The TT group had the highest peak SAP, at 2 min post-injection. However, the increase in SAP lasted longer in the LMA-6 group. There was no significant difference between the two groups (p=0.605).
Both the LMA-6 and TT groups had significant elevations in diastolic arterial pressure (DAP) 1-7 min and in mean arterial pressure (MAP) 1-8 min postinjection, respectively. Similarly, the TT group reached the highest peak DAP and MAP at 2 min after epinephrine administration. There was no significant difference between the groups (p=0.629 in DAP and p=0.642 in MAP). The HR increased in the TT group at 0.5 min and in the LMA-6 group at 1 min post-injection (p=0.028 and p=0.046, respectively). The effect persisted for 15 min in both groups. The TT group had the highest HR at 2 min. There was a significant difference between the two groups (p=0.01).
The control, LMA-and LMA-4 groups failed to display significant persistent (>2 min) hemodynamic changes after epinephrine administration.
Discussion
We tested increasing doses of LMAadministrated epinephrine and compared the effect with the standard tracheal route. After epinephrine administration, both the LMA-6 and TT groups had significant elevations in SAP, DAP, and MAP. Though there were no statistically significant differences between these two groups, the pattern of hemodynamic changes were distinct. In the TT group, the hemodynamic parameters peaked promptly after epinephrine administration, and then declined rapidly. The peak levels were higher than in the other groups. Those in the LMA-6 group increased more slowly and reached a plateau later. The differences in response presumably reflect different speeds of drug absorption, which are themselves the result of differences in the available area for absorption. With the LMA route, drug absorption occurs partly through the laryngeal mucosa and partly through the broncho-alveolar mucosa. With the TT route, all drug absorption is through the broncho-alveolar mucosa. Niemann et al. reported that epinephrine given at standard doses via a tracheal tube during cardiac arrest and cardiopulmonary resuscitation (CPR) was of no benefit. (14) European Resuscitation Council CPR guidelines recommend epinephrine delivery via tracheal tube only as the last resort. (15) The onset and the peak pharmacological effect of the LMA-6 group were slower and lower than in the TT group, and cardiac arrest is likely to further decrease drug effects. Therefore, unless higher than six times the tracheal dose is given, it is impractical to administer epinephrine via the LMA in resuscitation scenarios. LMA, laryngeal mask airway; TT, tracheal tube. LMA, laryngeal mask airway; TT, tracheal tube. LMA, laryngeal mask airway; TT, tracheal tube. cheal intubation, such as upper airway damage, infection, bradycardia and potentially catastrophic tracheal malpositioning. For certain drugs where a steady plateau effect instead of a high peak level is desired, the LMA is still an alternative route for drug delivery. However, given the smaller area of drug absorption for the LMA route, doses higher than those recommended for tracheal administration are likely to be required. There were a number of limitations to our study. First, the LMA fitted loosely in the pig larynx and leakage of epinephrine solution may have occurred, compromising interpretation of the drug effect. In addition, there was a TT in the trachea: although we deflated the cuff to reduce occlusion, the TT would have impeded dispersion of epinephrine into the broncho-alveolar area and may have led to an underestimate of the effects of LMA-administered epinephrine. Moreover, drug delivery via different airway devices involves different degrees of experimental stress, which may have led to variable changes of heart rate and arterial pressure.
Conclusions
In comparison with standard tracheal route, LMA administration of six times the standard tracheal dose of epinephrine achieved statistically equivalent hemodynamic changes. The effects achieved via the tracheal route peaked sooner but swiftly declined; those of LMA route rose more slowly and were maintained at a plateau. We could not identify an optimal LMA-administered epinephrine dose. Doses larger than those recommended for tracheal administration may be needed for drugs given via the LMA.
